This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cottagnoud, P.
Right arrow Articles by Täuber, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cottagnoud, P.
Right arrow Articles by Täuber, M. G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2002, p. 184-187, Vol. 46, No. 1
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.1.184-187.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Efficacies of BMS 284756 against Penicillin-Sensitive, Penicillin-Resistant, and Quinolone-Resistant Pneumococci in Experimental Meningitis

Philippe Cottagnoud,1* Fernando Acosta,2 Marianne Cottagnoud,2 Marc Pfister,3 and Martin G. Täuber4

Department of Internal Medicine, Inselspital,1 Department of Internal Medicine, Zieglerspital,2 Institute for Infectious Diseases, University of Bern, Bern, Switzerland,4 Department of Laboratory Medicine and Biopharmaceutical Sciences, University of California, San Francisco, California3

Received 22 February 2001/ Returned for modification 24 August 2001/ Accepted 15 October 2001

BMS 284756 penetrated well into inflamed meninges (44% ± 11%) and produced good bactericidal activity (-0.82 ± 0.22 {Delta}log10 CFU/ml · h) in the treatment of experimental meningitis in rabbits due to a penicillin-sensitive strain. BMS 284756 monotherapy had a greater potency than the standard regimen of ceftriaxone and vancomycin (-0.49 ± 0.08 {Delta}log10 CFU/ml · h) against a penicillin-resistant strain (MIC, 4 mg/liter). Even against a penicillin- and quinolone-resistant strain, BMS 284756 showed good bactericidal activity (-0.52 ± 0.12 {Delta}log10 CFU/ml · h). The antibacterial activity of BMS 284756 was confirmed by time-killing assays over 8 h in vitro.


* Corresponding author. Mailing address: Department of Internal Medicine, Inselspital, Bern, Switzerland. Phone: 41 316 322 111. Fax: 41 316 323 847. E-mail: pcottagn{at}insel.ch.


Antimicrobial Agents and Chemotherapy, January 2002, p. 184-187, Vol. 46, No. 1
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.1.184-187.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Cottagnoud, P., Pfister, M., Acosta, F., Cottagnoud, M., Flatz, L., Kuhn, F., Muller, H.-P., Stucki, A. (2004). Daptomycin Is Highly Efficacious against Penicillin-Resistant and Penicillin- and Quinolone-Resistant Pneumococci in Experimental Meningitis. Antimicrob. Agents Chemother. 48: 3928-3933 [Abstract] [Full Text]  
  • Entenza, J. M., Vouillamoz, J., Glauser, M. P., Moreillon, P. (2004). Efficacy of Garenoxacin in Treatment of Experimental Endocarditis Due to Staphylococcus aureus or Viridans Group Streptococci. Antimicrob. Agents Chemother. 48: 86-92 [Abstract] [Full Text]  
  • Cottagnoud, P., Pfister, M., Cottagnoud, M., Acosta, F., Tauber, M. G. (2003). Activities of Ertapenem, a New Long-Acting Carbapenem, against Penicillin-Sensitive or -Resistant Pneumococci in Experimental Meningitis. Antimicrob. Agents Chemother. 47: 1943-1947 [Abstract] [Full Text]  
  • Pfister, M., Zhang, L., Hammarlund-Udenaes, M., Sheiner, L. B., Gerber, C. M., Tauber, M. G., Cottagnoud, P. (2003). Modeling of Transfer Kinetics at the Serum-Cerebrospinal Fluid Barrier in Rabbits with Experimental Meningitis: Application to Grepafloxacin. Antimicrob. Agents Chemother. 47: 138-143 [Abstract] [Full Text]